Bruce G. Allen Investments’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$124K Sell
983
-6
-0.6% -$791 0.08% 131
2026
Q1
$138K Sell
989
-216
-18% -$30.2K 0.09% 114
2025
Q4
$148K Sell
1,205
-172
-12% -$20.9K 0.1% 110
2025
Q3
$153K Sell
1,377
-42
-3% -$4.77K 0.11% 102
2025
Q2
$157K Sell
1,419
-169
-11% -$18K 0.12% 96
2025
Q1
$178K Sell
1,588
-58
-4% -$5.99K 0.14% 79
2024
Q4
$152K Sell
1,646
-12
-0.7% -$1.08K 0.12% 101
2024
Q3
$139K Buy
1,658
+109
+7% +$8.32K 0.11% 119
2024
Q2
$106K Buy
1,549
+8
+0.5% +$534 0.09% 142
2024
Q1
$113K Buy
1,541
+212
+16% +$16.3K 0.09% 142
2023
Q4
$108K Buy
+1,329
New +$103K 0.1% 141

Other funds holding GILD

Bruce G. Allen Investments's GILD Position: Q2 2026 in Review

Bruce G. Allen Investments reduced its Gilead Sciences (GILD) stake by 0.61% in Q2 2026, selling an estimated $791 and leaving 983 shares worth $124K. The position accounts for 0.08% of the portfolio, ranked #131.

Bruce G. Allen Investments first reported a position in GILD in Q4 2023 and has held it in 11 quarters since. The position peaked at $178K in Q1 2025. 1,031 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Bruce G. Allen Investments held 983 shares of Gilead Sciences worth $124K as of Q2 2026.
  • Bruce G. Allen Investments sold 6 Gilead Sciences shares in Q2 2026, an estimated $791.
  • Gilead Sciences made up 0.08% of Bruce G. Allen Investments's portfolio in Q2 2026, its #131 holding.
  • Bruce G. Allen Investments first reported a position in Gilead Sciences in Q4 2023 and has held it in 11 quarters since.
  • Bruce G. Allen Investments's Gilead Sciences position peaked at $178K in Q1 2025.
  • 1,031 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Bruce G. Allen Investments's 13F filing for Q2 2026, filed 31 Jul 2026.